IL155992A0 - Pharmaceutical compositions for the oral delivery of pharmacologically active agents - Google Patents
Pharmaceutical compositions for the oral delivery of pharmacologically active agentsInfo
- Publication number
- IL155992A0 IL155992A0 IL15599201A IL15599201A IL155992A0 IL 155992 A0 IL155992 A0 IL 155992A0 IL 15599201 A IL15599201 A IL 15599201A IL 15599201 A IL15599201 A IL 15599201A IL 155992 A0 IL155992 A0 IL 155992A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmacologically active
- active agents
- pharmaceutical compositions
- oral delivery
- delivery
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 229960000913 crospovidone Drugs 0.000 abstract 1
- 229940124447 delivery agent Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 229940069328 povidone Drugs 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25172900P | 2000-12-06 | 2000-12-06 | |
| PCT/EP2001/014294 WO2002045754A2 (en) | 2000-12-06 | 2001-12-05 | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155992A0 true IL155992A0 (en) | 2003-12-23 |
Family
ID=22953160
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15599201A IL155992A0 (en) | 2000-12-06 | 2001-12-05 | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| IL155992A IL155992A (en) | 2000-12-06 | 2003-05-19 | Pharmacological preparations of pharmacologically active substances for oral administration |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL155992A IL155992A (en) | 2000-12-06 | 2003-05-19 | Pharmacological preparations of pharmacologically active substances for oral administration |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7049283B2 (de) |
| EP (1) | EP1341526B1 (de) |
| JP (2) | JP4898078B2 (de) |
| KR (1) | KR100847695B1 (de) |
| CN (1) | CN1304048C (de) |
| AT (1) | ATE513541T1 (de) |
| AU (2) | AU3454702A (de) |
| BR (2) | BR0115965A (de) |
| CA (1) | CA2436599C (de) |
| CY (1) | CY1112562T1 (de) |
| CZ (1) | CZ305418B6 (de) |
| DK (1) | DK1341526T3 (de) |
| EC (1) | ECSP034639A (de) |
| ES (1) | ES2367009T3 (de) |
| HU (1) | HU230632B1 (de) |
| IL (2) | IL155992A0 (de) |
| MX (1) | MXPA03005096A (de) |
| NO (1) | NO332936B1 (de) |
| NZ (1) | NZ526196A (de) |
| PL (1) | PL209703B1 (de) |
| PT (1) | PT1341526E (de) |
| RU (1) | RU2287999C2 (de) |
| SI (1) | SI1341526T1 (de) |
| SK (1) | SK287613B6 (de) |
| WO (1) | WO2002045754A2 (de) |
| ZA (1) | ZA200304295B (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000059863A1 (en) | 1999-04-05 | 2000-10-12 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
| JP5073153B2 (ja) * | 2001-06-01 | 2012-11-14 | ノバルティス アーゲー | 副甲状腺ホルモンおよびカルシトニンの経口投与 |
| US20050054557A1 (en) * | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
| TW200403052A (en) * | 2002-07-17 | 2004-03-01 | Novartis Ag | Use of organic compounds |
| PE20040724A1 (es) * | 2002-08-01 | 2004-12-06 | Novartis Ag | Composicion para la administracion oral de calcitonina |
| JP5546715B2 (ja) * | 2003-03-17 | 2014-07-09 | 日本たばこ産業株式会社 | Ｃｅｔｐ阻害剤の医薬組成物 |
| TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
| PT1651248E (pt) * | 2003-07-11 | 2009-11-10 | Novartis Ag | Composições farmacêuticas para dose oral compreendendo um agente de administração na forma micronizada |
| MXPA06000807A (es) * | 2003-07-23 | 2006-08-23 | Novartis Ag | Uso de calcitonina en osteoartritis. |
| PT1663182E (pt) * | 2003-09-12 | 2013-03-14 | Amgen Inc | Formulação de dissolução rápida de cinacalcet hcl |
| MXPA06013384A (es) * | 2004-05-19 | 2007-03-01 | Emisphere Tech Inc | Formulaciones topicas de cromolin. |
| GB0422644D0 (en) * | 2004-10-12 | 2004-11-10 | Novartis Ag | Organic compounds |
| GB0427603D0 (en) | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
| EP1843755B1 (de) * | 2005-02-01 | 2015-04-01 | Emisphere Technologies, Inc. | System zur magenretention und zur gesteuerten freisetzung |
| US8030271B2 (en) * | 2005-07-05 | 2011-10-04 | Emisphere Technologies, Inc. | Compositions and methods for buccal delivery of human growth hormone |
| KR20080049128A (ko) | 2005-09-19 | 2008-06-03 | 에미스페어 테크놀로지스, 인코포레이티드 | Ｎ-(5-클로로살리실로일)-8-아미노카프릴산 이나트륨염의결정형 |
| GB0522566D0 (en) * | 2005-11-04 | 2005-12-14 | Novartis Ag | Organic compounds |
| BRPI0618723A2 (pt) * | 2005-11-17 | 2011-09-06 | Novartis Ag | composição farmacêutica oral na forma de um comprimido prensado |
| JP2009527504A (ja) * | 2006-02-23 | 2009-07-30 | イオメディックス スリープ インターナショナル エスアールエル | 良質な睡眠の誘導および維持のための組成物および方法 |
| WO2008021088A2 (en) * | 2006-08-08 | 2008-02-21 | The Regents Of The University Of Californina | Salicylanilides enhance oral delivery of therapeutic peptides |
| US8323688B2 (en) * | 2006-08-31 | 2012-12-04 | Novartis Ag | Pharmaceutical compositions comprising hGH for oral delivery |
| CA2572004A1 (en) * | 2006-12-08 | 2008-06-08 | Bernard Charles Sherman | Tablets comprising entacapone and crospovidone |
| ATE507818T1 (de) * | 2007-03-02 | 2011-05-15 | Novartis Ag | Orale verabreichung eines calcitonins |
| PL2215047T3 (pl) | 2007-11-02 | 2014-05-30 | Emisphere Tech Inc | Sposób leczenia niedoborów witaminy b12 |
| CA2734442C (en) | 2008-08-18 | 2016-08-16 | Oramed Ltd | Methods and compositions for oral administration of proteins |
| KR101673042B1 (ko) * | 2009-03-12 | 2016-11-04 | 키바이오사이언스 아게 | 당뇨병 및 대사 증후군의 치료 |
| EA026713B1 (ru) * | 2010-06-09 | 2017-05-31 | Эмисфире Текнолоджис, Инк. | Твердая пероральная лекарственная форма для лечения дефицита железа или анемии и ее применение |
| PL3326620T3 (pl) | 2010-12-16 | 2020-08-24 | Novo Nordisk A/S | Kompozycje stałe zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino)kaprylowego |
| BR112013026195A2 (pt) | 2011-04-12 | 2016-11-29 | Novo Nordisk As | derivados de glp-1 duplamente acilados |
| CN111494323B (zh) | 2012-03-22 | 2023-03-28 | 诺和诺德股份有限公司 | 包含递送剂的组合物及其制备 |
| DK2827845T3 (en) | 2012-03-22 | 2019-04-01 | Novo Nordisk As | COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF |
| HUE062740T2 (hu) | 2012-03-22 | 2023-12-28 | Novo Nordisk As | GLP-1 peptidek készítményei és elõállításuk |
| US9993430B2 (en) | 2012-06-20 | 2018-06-12 | Novo Nordisk A/S | Tablet formulation comprising semaglutide and a delivery agent |
| PT2991671T (pt) | 2013-05-02 | 2018-11-05 | Novo Nordisk As | Dosagem oral de compostos de glp-1 |
| CN104961687B (zh) * | 2015-06-03 | 2017-07-25 | 苏州维泰生物技术有限公司 | 1,2‑二嗪衍生物及其制剂、用途 |
| MY189670A (en) * | 2015-07-08 | 2022-02-24 | Research & Business Found Sungkyunkwan Univ | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
| EA036204B1 (ru) * | 2015-10-16 | 2020-10-14 | Нобел Илач Санайи Ве Тиджарет А.Ш. | Фармацевтические композиции нилотиниба гидрохлорида |
| CN107080739A (zh) * | 2017-04-17 | 2017-08-22 | 深圳市泛谷药业股份有限公司 | 一种用于口服给药的固体快速释放布南色林片及其制备方法 |
| SG11202006595RA (en) | 2018-02-02 | 2020-08-28 | Novo Nordisk As | Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant |
| JP2021054781A (ja) * | 2019-09-26 | 2021-04-08 | デボン エルエス，リミテッド | 共結晶形エフィナコナゾール、及びその製造方法 |
| KR102301743B1 (ko) * | 2020-12-29 | 2021-09-13 | 대봉엘에스 주식회사 | 에피나코나졸 경구용 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015633A (en) | 1987-04-27 | 1991-05-14 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| US5756450A (en) | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
| US5002771A (en) | 1989-02-06 | 1991-03-26 | Rorer Pharmaceutical Corp. | Calcitonin suppository formulations |
| IT1238072B (it) | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
| JPH052771A (ja) * | 1991-06-25 | 1993-01-08 | Pioneer Electron Corp | 光記録媒体 |
| US5681811A (en) | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| DE69520292T2 (de) | 1994-12-14 | 2001-06-13 | Bioglan Ireland (R & D) Ltd., Dublin | Pharmazeutische zubereitung zur direktverpressung |
| US5866536A (en) | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| CN1151836C (zh) * | 1995-03-31 | 2004-06-02 | 艾米斯菲尔技术有限公司 | 用作传送活性剂的化合物和组合物 |
| US5912014A (en) * | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| US5972381A (en) | 1996-06-28 | 1999-10-26 | Schering Corporation | Solid solution of an antifungal agent with enhanced bioavailability |
| US5958453A (en) | 1996-10-31 | 1999-09-28 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility |
| US5773647A (en) | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| CA2319672C (en) | 1997-02-07 | 2011-01-04 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| SK13632000A3 (sk) | 1998-03-16 | 2001-03-12 | Inhale Therapeutic Systems, Inc. | Spôsob podávania aktívnej látky do pľúc ľudského pacienta a zariadenie na jeho vykonávanie |
| AU3574500A (en) | 1999-03-25 | 2000-10-16 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| WO2000059480A1 (en) * | 1999-04-05 | 2000-10-12 | Emisphere Technologies, Inc. | Lyophilized solid dosage forms and methods of making |
| WO2000059863A1 (en) * | 1999-04-05 | 2000-10-12 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
-
2001
- 2001-12-04 US US10/006,311 patent/US7049283B2/en not_active Expired - Fee Related
- 2001-12-05 DK DK01985368.8T patent/DK1341526T3/da active
- 2001-12-05 JP JP2002547536A patent/JP4898078B2/ja not_active Expired - Fee Related
- 2001-12-05 CA CA2436599A patent/CA2436599C/en not_active Expired - Fee Related
- 2001-12-05 SI SI200130999T patent/SI1341526T1/sl unknown
- 2001-12-05 PL PL362247A patent/PL209703B1/pl unknown
- 2001-12-05 CZ CZ2003-1566A patent/CZ305418B6/cs not_active IP Right Cessation
- 2001-12-05 BR BR0115965-8A patent/BR0115965A/pt not_active IP Right Cessation
- 2001-12-05 AU AU3454702A patent/AU3454702A/xx active Pending
- 2001-12-05 NZ NZ526196A patent/NZ526196A/en not_active IP Right Cessation
- 2001-12-05 RU RU2003119545/15A patent/RU2287999C2/ru not_active IP Right Cessation
- 2001-12-05 KR KR1020037007098A patent/KR100847695B1/ko not_active Expired - Fee Related
- 2001-12-05 CN CNB018201423A patent/CN1304048C/zh not_active Expired - Fee Related
- 2001-12-05 HU HU0302319A patent/HU230632B1/hu not_active IP Right Cessation
- 2001-12-05 EP EP01985368A patent/EP1341526B1/de not_active Expired - Lifetime
- 2001-12-05 IL IL15599201A patent/IL155992A0/xx active IP Right Grant
- 2001-12-05 MX MXPA03005096A patent/MXPA03005096A/es active IP Right Grant
- 2001-12-05 ES ES01985368T patent/ES2367009T3/es not_active Expired - Lifetime
- 2001-12-05 PT PT01985368T patent/PT1341526E/pt unknown
- 2001-12-05 AT AT01985368T patent/ATE513541T1/de active
- 2001-12-05 AU AU2002234547A patent/AU2002234547B2/en not_active Ceased
- 2001-12-05 WO PCT/EP2001/014294 patent/WO2002045754A2/en not_active Ceased
- 2001-12-05 BR BRPI0115965-8A patent/BRPI0115965B1/pt unknown
- 2001-12-05 SK SK688-2003A patent/SK287613B6/sk not_active IP Right Cessation
-
2003
- 2003-05-19 IL IL155992A patent/IL155992A/en not_active IP Right Cessation
- 2003-06-02 ZA ZA200304295A patent/ZA200304295B/en unknown
- 2003-06-03 NO NO20032511A patent/NO332936B1/no not_active IP Right Cessation
- 2003-06-04 EC EC2003004639A patent/ECSP034639A/es unknown
-
2009
- 2009-04-13 JP JP2009097262A patent/JP2009185052A/ja not_active Withdrawn
-
2011
- 2011-08-09 CY CY20111100759T patent/CY1112562T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3454702A (en) | Pharmaceutical compositions for the oral delivery of pharmacologically active agents | |
| PL1651248T3 (pl) | Doustnie dawkowana kompozycja farmaceutyczna zawierająca środek dostarczający w postaci mikronizowanej | |
| ITMI20001173A0 (it) | Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva. | |
| PL348734A1 (en) | New sustained release oral formulations | |
| EP1392241A4 (de) | System für die osmotische freisetzung von pharmazeutisch wirksamen mitteln | |
| YU68199A (sh) | Farmaceutske formulacije koje sadrže vorikonazol | |
| AU2001283563A1 (en) | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent | |
| IL166561A0 (en) | Pharmaceutical compositions | |
| IL157741A0 (en) | Pharmaceutical compositions containing an antihyperplastic active agent | |
| IL163552A (en) | Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same | |
| IS6263A (is) | Lyfjasamsetningar, sem innihalda trípeptíð | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| IL151909A0 (en) | Peptide conjugates for drug delivery | |
| IL157540A0 (en) | N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof | |
| WO2003041656A3 (en) | Soluble drug extended release system | |
| HUP0303860A3 (en) | A pharmaceutical tablet having a high active ingredient | |
| BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
| MY136370A (en) | Oxazolidinone tablet formulation | |
| GB0001315D0 (en) | Organic compounds | |
| MXPA01008348A (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
| AU5654701A (en) | Drug delivery mask | |
| DE69904020D1 (de) | Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid | |
| WO2005062722A3 (en) | Fexofenadine containing pharmaceutical formulation | |
| AU2502301A (en) | Medicament and combination of compatible medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |